Business Description
Orion Pharma Ltd
ISIN : BD0486OPL004
Total Employee Number:
2,954Compare
Compare
Traded in other countries / regions
ORIONPHARM.Bangladesh IPO Date
2013-03-20Description
Orion Pharma Ltd is a pharmaceutical company engaged in the creation and discovery, development, manufacturing, and marketing of pharmaceutical products, including vaccines and health-related consumer products. The company produces diversified dosage forms such as tablets, capsules, syrups, solutions, suspensions, powder for suspensions, creams, ointments, and injections under therapeutic categories including cardiovascular, antiulcerant, antiasthmatic, antihistamine, NSAIDs, antibiotic, antifungal, laxatives, anticancer, vitamins, and minerals. In addition, the company is involved in power generation activities and generates maximum revenue from pharmaceutical activities. The group principally carries out its business operations and markets its products in Bangladesh.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | 0.35 | |||||
Debt-to-Equity | 1.35 | |||||
Debt-to-EBITDA | 62.5 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 0.52 | |||||
Beneish M-Score | -2.9 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -25 | |||||
3-Year EBITDA Growth Rate | -26.7 | |||||
3-Year Book Growth Rate | 1.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 54.95 | |||||
9-Day RSI | 58.07 | |||||
14-Day RSI | 58.74 | |||||
3-1 Month Momentum % | -11.99 | |||||
6-1 Month Momentum % | -7.55 | |||||
12-1 Month Momentum % | -16.01 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.06 | |||||
Quick Ratio | 1.93 | |||||
Cash Ratio | 0.02 | |||||
Days Inventory | 223.14 | |||||
Days Sales Outstanding | 422.55 | |||||
Days Payable | 875.27 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | -5.9 | |||||
Shareholder Yield % | -43.99 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 37.89 | |||||
Operating Margin % | -3.34 | |||||
Net Margin % | -19.34 | |||||
EBITDA Margin % | 11.51 | |||||
FCF Margin % | 10.66 | |||||
OCF Margin % | 21.86 | |||||
ROE % | -3.56 | |||||
ROA % | -1.29 | |||||
ROIC % | -0.26 | |||||
3-Year ROIIC % | -6.25 | |||||
ROC (Joel Greenblatt) % | -0.46 | |||||
ROCE % | -0.3 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shiller PE Ratio | 9.74 | |||||
PS Ratio | 1.77 | |||||
PB Ratio | 0.34 | |||||
Price-to-Tangible-Book | 0.33 | |||||
Price-to-Free-Cash-Flow | 16.63 | |||||
Price-to-Operating-Cash-Flow | 8.11 | |||||
EV-to-EBIT | -243.97 | |||||
EV-to-EBITDA | 80.89 | |||||
EV-to-Revenue | 9.31 | |||||
EV-to-FCF | 87.48 | |||||
Price-to-GF-Value | 1.4 | |||||
Price-to-Projected-FCF | 0.83 | |||||
Price-to-Median-PS-Value | 1.36 | |||||
Earnings Yield (Greenblatt) % | -0.41 | |||||
FCF Yield % | 6.01 | |||||
Forward Rate of Return (Yacktman) % | -37.43 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Orion Pharma Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil BDT) | 3,759.265 | ||
| EPS (TTM) (BDT) | -3.108 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.98 | ||
| 3-Year Sortino Ratio | -1.19 | ||
| Volatility % | 43.73 | ||
| 14-Day RSI | 58.74 | ||
| 14-Day ATR (BDT) | 0.844516 | ||
| 20-Day SMA (BDT) | 27.89 | ||
| 12-1 Month Momentum % | -16.01 | ||
| 52-Week Range (BDT) | 22.9 - 42.7 | ||
| Shares Outstanding (Mil) | 234 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Orion Pharma Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Orion Pharma Ltd Stock Events
| Event | Date | Price (BDT) | ||
|---|---|---|---|---|
| BDT 1.000000 Cash Dividend | 2024-12-05 | 39.80 (+0.00%) | ||
| 1.2:1 Stock Split | 2013-05-27 | 64.25 (+0.00%) |
Show
Entries
Orion Pharma Ltd Frequently Asked Questions
What is Orion Pharma Ltd(DHA:ORIONPHARM)'s stock price today?
The current price of DHA:ORIONPHARM is BDT28.50. The 52 week high of DHA:ORIONPHARM is BDT42.70 and 52 week low is BDT22.90.
When is next earnings date of Orion Pharma Ltd(DHA:ORIONPHARM)?
The next earnings date of Orion Pharma Ltd(DHA:ORIONPHARM) is .
Does Orion Pharma Ltd(DHA:ORIONPHARM) pay dividends? If so, how much?
Orion Pharma Ltd(DHA:ORIONPHARM) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Orion Pharma Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers